Feb 20,2015

Tandem Diabetes Care Launches t:simulator™ Demonstration App

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced the release of the t:simulator™ App, which mimics the touchscreen interface and features of the t:slim Insulin Pump. The t:simulator App is compatible with iPhone®, iPad® and iPod touch® and is available on the App Store℠ at no charge. A version of the app for Android™ is currently in development.

PRODUCT

#insulin pump

#mobile app

View Analyst & Ambassador Comments
Go to original news
Feb 24,2015

Tandem Diabetes Care Reports Fourth Quarter and Full Year 2014 Financial Results

Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2014. For the year ended December 31, 2014, gross margin was 31 percent compared to a gross margin of 21 percent for the same period of 2013. For the year ended December 31, 2014, operating expenses totaled $90.9 million compared to $55.6 million for the same period of 2013.

View Analyst & Ambassador Comments
Go to original news
Feb 26,2015

Insulet Reports Fourth Quarter and Full Year 2014 Financial Results

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced financial results for the three months and full year ended December 31, 2014. Fourth quarter 2014 revenue increased 6% to $72.6 million, compared with $68.5 million in the fourth quarter of 2013. For the year ended December 31, 2014, revenue increased 17% to $288.7 million from $247.1 million in 2013.

View Analyst & Ambassador Comments
Go to original news
Feb 26,2015

Insulet Corporation to Assume Distribution Rights for OmniPod System in Canada

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that following a four year distribution agreement with GlaxoSmithKline (GSK), the Company will assume full rights to distribute the OmniPod System in the Canadian market via a newly created Canadian Subsidiary, Insulet Canada Corporation. This will include all sales, marketing, training and support activities. The transfer is expected to be complete by end of June 2015.

PRODUCT

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Feb 27,2015

Tandem Diabetes Care to Present at the Cowen and Company 35th Annual Health Care Conference

Tandem Diabetes Care®, Inc. (Nasdaq:TNDM), a medical device company and manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced that Kim Blickenstaff, president and CEO, will present a company update at the Cowen and Company 35th Annual Health Care Conference in Boston, MA. The presentation will take place on Tuesday, March 3, 2015 at 9:20am Eastern Time (6:20am Pacific Time).

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Feb 28,2015

Insulet Corporation to Present at Upcoming Investor Conferences

Insulet Corporation (NASDAQ: PODD), the leader in tubeless insulin pump technology with its OmniPod® Insulin Management System, today announced that management will present at the following upcoming investor conferences: The Raymond James 36th Annual Institutional Investors Conference & The Cowen and Company 35th Annual Health Care Conference.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Mar 02,2015

Novo Nordisk talks up its broader strategy for diabetes marketing

Jeremy Shepler, senior director of diabetes marketing at Novo Nordisk, spoke at the ePharma Summit last week about some of the ways Novo Nordisk is supporting diabetes patients by taking a long view of the condition. Novo Nordisk has launched several programs aimed at getting more patients with diabetes screened and into treatment in the first place, and though they all feature the Novo Nordisk logo, they're not pushing any particular product.

View Analyst & Ambassador Comments
Go to original news
Mar 04,2015

Think apps are easy to design? Guess again

A German survey of elderly diabetics is proving that it isn't easy to design a chronic disease management app that will be widely used. Conducted by the Dresden University of Technology and Public Health Saxony and published in the Journal of Medical Internet Research (JMIR), the survey of 32 elderly diabetic patients found that only 6 percent are using apps. When asked what would make a diabetes app useful for them, 32 percent wanted the ability to add remarks to measured values, while 25 percent wanted clear definitions of threshold values and alerts when those thresholds deviated, and 25 percent wanted a reminder feature for measuring and taking medications.

#mobile app

View Analyst & Ambassador Comments
Go to original news
Mar 05,2015

Study: Interactive, tailored web content may improve patient health, knowledge

Offering interactive web-based content that is personalized for a patient may increase the patient's knowledge of their condition and reduce their incidence of negative effects, according to a study conducted by researchers in the Department of Medical Psychology at Germany-based University Medical Center Hamburg-Eppendorf. Researchers recruited 179 people with type 2 diabetes and 382 that had chronic back pain.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Mar 11,2015

HealthTap Launches RateRx, A Doctor Recommendation System For Drug Treatments

HealthTap is known for offering on-demand patient treatment services through its app. RateRx launches as a new service on HealthTap that will be a sort of Yelp-like, doctor-recommended drug-review database. Currently, doctors review medication treatments for conditions such as acne, arthritis, anxiety, diabetes, headaches and hypertension.

PRODUCT

#mobile app

View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES